Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@m72068958 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1310244506969583617.png) @m72068958 다율잉(DaYule)

다율잉(DaYule) posts on X about $crsp, crispr, files, vivo the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours.

### Engagements: X [#](/creator/twitter::1310244506969583617/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1310244506969583617/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Months XXXXX -XX%
- X Year XXXXXX +1,114%

### Mentions: X [#](/creator/twitter::1310244506969583617/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1310244506969583617/c:line/m:posts_active.svg)

- X Week X no change
- X Months X -XX%
- X Year XX +329%

### Followers: XX [#](/creator/twitter::1310244506969583617/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1310244506969583617/c:line/m:followers.svg)

- X Week XX +3.70%
- X Month XX +17%
- X Months XX +30%

### CreatorRank: undefined [#](/creator/twitter::1310244506969583617/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1310244506969583617/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1310244506969583617/influence)
---

**Social category influence**
[technology brands](/list/technology-brands) 

**Social topic influence**
[$crsp](/topic/$crsp) #24, [crispr](/topic/crispr) #16, [files](/topic/files), [vivo](/topic/vivo), [future of](/topic/future-of), [targets](/topic/targets)

**Top assets mentioned**
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp)
### Top Social Posts [#](/creator/twitter::1310244506969583617/posts)
---
Top posts by engagements in the last XX hours

"$CRSP files patent for SyNTase (US 99421485) Evolving into a next-generation in vivo gene-editing platform company. With proof-of-concept data showing up to XX% editing efficiency SyNTase could redefine the future of gene therapy. Watch #CRSP. #CRISPR #SyNTase #GeneEditing"  
[X Link](https://x.com/m72068958/status/1974273962910925090) [@m72068958](/creator/x/m72068958) 2025-10-04T00:42Z XX followers, 1721 engagements


"1. Big moment for $CRSP. CRISPR Therapeutics just presented new preclinical data for CTX460 the first candidate from its SyNTase gene editing platform at #ESGCT2025. It targets Alpha-1 Antitrypsin Deficiency (AATD) a rare liver & lung disease with no curative options"  
[X Link](https://x.com/m72068958/status/1976619928737435660) [@m72068958](/creator/x/m72068958) 2025-10-10T12:04Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@m72068958 Avatar @m72068958 다율잉(DaYule)

다율잉(DaYule) posts on X about $crsp, crispr, files, vivo the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

Engagements Line Chart

  • X Week XXX -XX%
  • X Months XXXXX -XX%
  • X Year XXXXXX +1,114%

Mentions: X #

Mentions Line Chart

  • X Week X no change
  • X Months X -XX%
  • X Year XX +329%

Followers: XX #

Followers Line Chart

  • X Week XX +3.70%
  • X Month XX +17%
  • X Months XX +30%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence technology brands

Social topic influence $crsp #24, crispr #16, files, vivo, future of, targets

Top assets mentioned CRISPR Therapeutics AG (CRSP)

Top Social Posts #


Top posts by engagements in the last XX hours

"$CRSP files patent for SyNTase (US 99421485) Evolving into a next-generation in vivo gene-editing platform company. With proof-of-concept data showing up to XX% editing efficiency SyNTase could redefine the future of gene therapy. Watch #CRSP. #CRISPR #SyNTase #GeneEditing"
X Link @m72068958 2025-10-04T00:42Z XX followers, 1721 engagements

"1. Big moment for $CRSP. CRISPR Therapeutics just presented new preclinical data for CTX460 the first candidate from its SyNTase gene editing platform at #ESGCT2025. It targets Alpha-1 Antitrypsin Deficiency (AATD) a rare liver & lung disease with no curative options"
X Link @m72068958 2025-10-10T12:04Z XX followers, XXX engagements

@m72068958
/creator/twitter::m72068958